John B. Bode - Sep 5, 2023 Form 4 Insider Report for ZEVRA THERAPEUTICS, INC. (ZVRA)

Role
Director
Signature
/s/ Timothy J. Sangiovanni, Attorney-in-Fact for John B. Bode
Stock symbol
ZVRA
Transactions as of
Sep 5, 2023
Transactions value $
$51,333
Form type
4
Date filed
9/6/2023, 04:40 PM
Previous filing
May 19, 2023
Next filing
Dec 1, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ZVRA Common Stock Purchase $51.3K +10K +100% $5.13 20K Sep 5, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.12 to $5.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.